Reference
Medicines and Healthcare products Regulatory Agency (UK). Obeticholic acid (Ocaliva): risk of serious liver injury in patients with pre-existing moderate or severe hepatic impairment; reminder to adjust dosing according to liver function monitoring. Drug Safety Update 11: 6-7, No. 9, Apr 2018. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/701831/DSU-April-2018-PDF.pdf
Rights and permissions
About this article
Cite this article
Serious hepatic injuries, death associated with Ocaliva. Reactions Weekly 1701, 7 (2018). https://doi.org/10.1007/s40278-018-45839-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-45839-8